Nausea remains its most common side effect at approximately 40% of patients, though this typically attenuates after the first dose
It can cause some side effects including stomach upset, nausea, vomiting, dry mouth, headache, and restlessness
6.2 Future prospect Although curcumin has demonstrated potential neuroprotective effects, it is important to highlight that the clinical transformation still encounters numerous challenges and requires further investigation: (1) Most curcumin formulations used in current studies are complex mixtures primarily consisting of curcumin, demethoxycurcumin and bisdemethoxycurcumin
Service availability is described as subject to change based on state regulations and clinician licensure, so it's worth checking directly with HumeCare if your situation changes or if you're evaluating this program for future use
List of GLP-1 drugs Here are some FDA-approved GLP-1 receptor agonists: Semaglutide (Ozempic, Wegovy, Rybelsus) Liraglutide (Victoza, Saxenda) Dulaglutide (Trulicity) Exenatide (Byetta, Bydureon) Lixisenatide (Adlyxin) Tirzepatide (Mounjaro), technically a dual GIP/GLP-1 agonist How do GLP-1 agonists work
References Agere S, Akhtar N, Riegsecker S, Ahmed S (2015) Epigallocatechin-3-gallate (egcg) inhibits rantes/ccl5 induced mmp-1 and mmp-13 expression in human rheumatoid arthritis synovial fibroblasts
